Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Neoplasm Staging"" wg kryterium: Temat


Tytuł:
The prognostic value of 11 AJCC staging systems in Chinese patients with esophageal squamous cell carcinoma.
Autorzy:
Zhang XQ; Shandong First Medical University, Jinan, 250000, Shandong, China.; Department of Radiotherapy, Xingning People's Hospital, Xingning, 514599, Guangdong, China.
Miao CW; Shandong First Medical University, Jinan, 250000, Shandong, China.; Department of Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
Liu LP; Shandong First Medical University, Jinan, 250000, Shandong, China.; Department of Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
Wang CL; Shandong First Medical University, Jinan, 250000, Shandong, China.; Department of Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
Chen JZ; Shandong First Medical University, Jinan, 250000, Shandong, China.; Department of Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
Li WH; Shandong First Medical University, Jinan, 250000, Shandong, China.; Department of Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
Hu XD; Shandong First Medical University, Jinan, 250000, Shandong, China. .; Department of Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China. .
Pokaż więcej
Źródło:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2023 Aug 23; Vol. 18 (1), pp. 251. Date of Electronic Publication: 2023 Aug 23.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/pathology
Esophageal Neoplasms*/surgery
Esophageal Squamous Cell Carcinoma*/pathology
Esophageal Squamous Cell Carcinoma*/surgery
Neoplasm Staging*
Aged ; Humans ; Middle Aged ; East Asian People ; Prognosis ; Retrospective Studies ; Survival Analysis
Czasopismo naukowe
Tytuł:
Obstetric outcomes after medroxyprogesterone acetate treatment for early stage endometrial cancer or atypical endometrial hyperplasia: a single hospital-based study.
Autorzy:
Oishi M; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Kasuga Y; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan. .
Fukuma Y; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Hamuro A; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Tamai J; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Tanaka Y; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Hasegawa K; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Yoshimura T; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Ikenoue S; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Ochiai D; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.; Department of Obstetrics and Gynecology, School of Medicine, Kitasato University, 1-15-1, Kitasato, Minami-Ku, Sagamihara-Shi, Kanagawa, 252-0375, Japan.
Yamagami W; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Tanaka M; Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Pokaż więcej
Źródło:
International journal of clinical oncology [Int J Clin Oncol] 2023 Apr; Vol. 28 (4), pp. 587-591. Date of Electronic Publication: 2023 Jan 20.
Typ publikacji:
Journal Article
MeSH Terms:
Endometrial Hyperplasia*/drug therapy
Endometrial Neoplasms*/drug therapy
Endometrial Neoplasms*/pathology
Hospitals*
Medroxyprogesterone Acetate*/adverse effects
Medroxyprogesterone Acetate*/therapeutic use
Neoplasm Staging*
Placenta Accreta*/chemically induced
Placenta Accreta*/etiology
Female ; Humans ; Pregnancy ; Dilatation and Curettage ; Premature Birth ; Retrospective Studies ; Obstetrics ; Adult ; Middle Aged
Czasopismo naukowe
Tytuł:
Quality of surgery and treatment and its association with hospital volume: A population-based study in more than 5000 Belgian ovarian cancer patients.
Autorzy:
Bourgeois J; Belgian Health Care Knowledge Centre (KCE), Kruidtuinlaan 55, Brussels, B-1000, Belgium. Electronic address: .
Peacock HM; Belgian Cancer Registry, Koningsstraat 215, Bus7, Brussels, B-1210, Belgium.
Savoye I; Belgian Health Care Knowledge Centre (KCE), Kruidtuinlaan 55, Brussels, B-1000, Belgium.
De Gendt C; Belgian Cancer Registry, Koningsstraat 215, Bus7, Brussels, B-1210, Belgium.
Leroy R; Belgian Health Care Knowledge Centre (KCE), Kruidtuinlaan 55, Brussels, B-1000, Belgium.
Silversmit G; Belgian Cancer Registry, Koningsstraat 215, Bus7, Brussels, B-1210, Belgium.
Stordeur S; Belgian Health Care Knowledge Centre (KCE), Kruidtuinlaan 55, Brussels, B-1000, Belgium.
de Sutter P; Department Gynaecology-Oncology, UZ Brussel - VUB, Brussels, B-1210, Belgium.
Goffin F; Department of Obstetrics and Gynaecology, University Hospital of Liège, Liège, Belgium.
Luyckx M; Service de Gynécologie et Andrologie and Institut Roi Albert II, Cliniques Universitaires Saint-Luc, UCLouvain, Brussel, Belgium.
Orye G; Department of Obstetrics and Gynecology, Jessa Hospital, Hasselt, Belgium.
Van Dam P; Division of Gynecological Oncology, Multidisciplinary Oncologic Centre, Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium.
Van Gorp T; University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium.
Verleye L; Belgian Health Care Knowledge Centre (KCE), Kruidtuinlaan 55, Brussels, B-1000, Belgium.
Pokaż więcej
Źródło:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2024 Mar; Vol. 50 (3), pp. 107978. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/surgery
Ovarian Neoplasms*/pathology
Humans ; Female ; Belgium/epidemiology ; Lymph Nodes/pathology ; Lymph Node Excision/methods ; Hospitals, High-Volume ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Outcomes and potential impact of a virtual hands-on training program on MRI staging confidence and performance in rectal cancer.
Autorzy:
El Khababi N; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1106 BE, Amsterdam, The Netherlands.; GROW School for oncology and reproduction, University of Maastricht, Maastricht, The Netherlands.
Beets-Tan RGH; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1106 BE, Amsterdam, The Netherlands.; GROW School for oncology and reproduction, University of Maastricht, Maastricht, The Netherlands.
Tissier R; Biostatistics Unit, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Lahaye MJ; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1106 BE, Amsterdam, The Netherlands.; GROW School for oncology and reproduction, University of Maastricht, Maastricht, The Netherlands.
Maas M; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1106 BE, Amsterdam, The Netherlands.; GROW School for oncology and reproduction, University of Maastricht, Maastricht, The Netherlands.
Curvo-Semedo L; Department of Radiology, Centro Hospitalar E Universitario de Coimbra EPE, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Dresen RC; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
van Griethuysen JJM; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1106 BE, Amsterdam, The Netherlands.; Department of Radiology, UMC Utrecht, Utrecht, The Netherlands.
Nougaret S; Medical Imaging Department, Montpellier Cancer Institute, Montpellier Cancer Research Institute (U1194), University of Montpellier, Montpellier, France.
Beets GL; GROW School for oncology and reproduction, University of Maastricht, Maastricht, The Netherlands.; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Triest B; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Taylor SA; Department of Radiology, University College London Hospitals Biomedical Research Centre, London, UK.
Lambregts DMJ; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1106 BE, Amsterdam, The Netherlands. .; GROW School for oncology and reproduction, University of Maastricht, Maastricht, The Netherlands. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Mar; Vol. 34 (3), pp. 1746-1754. Date of Electronic Publication: 2023 Aug 30.
Typ publikacji:
Journal Article
MeSH Terms:
Rectal Neoplasms*/pathology
Humans ; Magnetic Resonance Imaging/methods ; Rectum/pathology ; Neoplasm Staging ; Hand
Czasopismo naukowe
Tytuł:
Diagnostic performance and prognostic value of CT-defined visceral pleural invasion in early-stage lung adenocarcinomas.
Autorzy:
Lim WH; Department of Radiology, Seoul National University Hospital, Seoul, Korea.
Lee KH; Department of Radiology, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.; Department of Radiology, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-Do, Korea.
Lee JH; Department of Radiology, Seoul National University Hospital, Seoul, Korea.
Park H; Department of Radiology, Seoul National University Hospital, Seoul, Korea.
Nam JG; Department of Radiology, Seoul National University Hospital, Seoul, Korea.
Hwang EJ; Department of Radiology, Seoul National University Hospital, Seoul, Korea.; Department of Radiology, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.
Chung JH; Department of Pathology and Translational Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Gyeonggi-Do, Korea.
Goo JM; Department of Radiology, Seoul National University Hospital, Seoul, Korea.; Department of Radiology, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.; Seoul National University Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Korea.
Park S; Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine, Seoul, Korea.; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Korea.
Kim YT; Seoul National University Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine, Seoul, Korea.; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Korea.
Kim H; Department of Radiology, Seoul National University Hospital, Seoul, Korea. .; Department of Radiology, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Mar; Vol. 34 (3), pp. 1934-1945. Date of Electronic Publication: 2023 Sep 02.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Aged ; Female ; Humans ; Neoplasm Staging ; Pleura/diagnostic imaging ; Pleura/pathology ; Prognosis ; Tomography, X-Ray Computed ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
Impact of PSMA PET on Prostate Cancer Management.
Autorzy:
Weiner AB; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA. .; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA. .
Agrawal R; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA.; Department of Human Genetics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA.
Valle LF; Department of Radiation Oncology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Sonni I; Department of Radiological Sciences, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.; Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy.
Kishan AU; Department of Radiation Oncology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Rettig MB; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.; Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Raman SS; Department of Radiological Sciences, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Boutros PC; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA.; Department of Human Genetics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA.
Reiter RE; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA.
Pokaż więcej
Źródło:
Current treatment options in oncology [Curr Treat Options Oncol] 2024 Feb; Vol. 25 (2), pp. 191-205. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antigens, Surface*
Prostatic Neoplasms*/therapy
Prostatic Neoplasms*/drug therapy
Humans ; Male ; Neoplasm Staging ; Positron Emission Tomography Computed Tomography/methods ; Prospective Studies ; Radiopharmaceuticals/therapeutic use ; Prostate-Specific Antigen
Czasopismo naukowe
Tytuł:
Diagnostic yield of contrast-enhanced abdominal staging CT in patients with initially diagnosed breast cancer.
Autorzy:
Jeong B; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea.
Lee YW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea.
Lee SB; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea.
Kim J; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea.
Son BH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea.
Gwark S; Department of Surgery, Ewha Womens University Mokdong Hospital, Seoul, Republic of Korea.
Shin HJ; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea.
Yoo TK; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea. Electronic address: .
Choi SH; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło:
European journal of radiology [Eur J Radiol] 2024 Feb; Vol. 171, pp. 111295. Date of Electronic Publication: 2024 Jan 08.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/metabolism
Liver Neoplasms*/pathology
Humans ; Adult ; Middle Aged ; Female ; Neoplasm Staging ; Retrospective Studies ; Receptor, ErbB-2/metabolism ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
Evaluation of pre-therapeutic imaging work-up in the staging of endometrial cancer: Interest in a systematic second opinion in a cancer center.
Autorzy:
Baijnath P; Service d'imagerie médicale et de radiologie, Institut de Cancérologie de Lorraine Alexis Vautrin, Vandoeuvre-les-Nancy F-54500, France. Electronic address: .
Pelissier M; Service d'imagerie médicale et de radiologie, Institut de Cancérologie de Lorraine Alexis Vautrin, Vandoeuvre-les-Nancy F-54500, France.
Sahki N; Unité de biostatistique, Institut de Cancérologie de Lorraine Alexis Vautrin, Vandoeuvre-les-Nancy, France.
Henrot P; Service d'imagerie médicale et de radiologie, Institut de Cancérologie de Lorraine Alexis Vautrin, Vandoeuvre-les-Nancy F-54500, France.
Pokaż więcej
Źródło:
Journal of gynecology obstetrics and human reproduction [J Gynecol Obstet Hum Reprod] 2024 Feb; Vol. 53 (2), pp. 102716. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Magnetic Resonance Imaging*/methods
Endometrial Neoplasms*/diagnostic imaging
Endometrial Neoplasms*/therapy
Endometrial Neoplasms*/pathology
Female ; Humans ; Neoplasm Staging ; Referral and Consultation ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
The diagnostic accuracy of local staging in colon cancer based on computed tomography (CT): evaluating the role of extramural venous invasion and tumour deposits.
Autorzy:
van den Berg K; Department of Medical Oncology, Catharina Hospital, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands. .; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands. .
Wang S; Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands.
Willems JMWE; Department of Medical Oncology, Anna Hospital, Geldrop, The Netherlands.
Creemers GJ; Department of Medical Oncology, Catharina Hospital, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands.
Roodhart JML; Department of Medical Oncology, University Medical Centre, Utrecht, The Netherlands.
Shkurti J; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Burger JWA; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
Rutten HJT; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Beets-Tan RGH; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Nederend J; Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands.
Pokaż więcej
Źródło:
Abdominal radiology (New York) [Abdom Radiol (NY)] 2024 Feb; Vol. 49 (2), pp. 365-374. Date of Electronic Publication: 2023 Nov 29.
Typ publikacji:
Journal Article
MeSH Terms:
Extranodal Extension*/pathology
Colonic Neoplasms*/diagnostic imaging
Colonic Neoplasms*/pathology
Humans ; Retrospective Studies ; Tomography, X-Ray Computed/methods ; Neoplasm Staging ; Neoplasm Invasiveness/pathology
Czasopismo naukowe
Tytuł:
Small arteriole sign: an imaging feature for staging T4a colon cancer.
Autorzy:
Guan Z; Departments of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fu Cheng Road, Hai Dian District, Beijing, 100142, China.
Li ZW; Departments of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fu Cheng Road, Hai Dian District, Beijing, 100142, China.
Yang D; Departments of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fu Cheng Road, Hai Dian District, Beijing, 100142, China.
Yu T; Department of Medical Imaging, Liaoning Cancer Hospital & Institute, Shenyang, 110042, China.
Jiang HJ; Department of Radiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
Zhang XY; Departments of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fu Cheng Road, Hai Dian District, Beijing, 100142, China. .
Yan S; Departments of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fu Cheng Road, Hai Dian District, Beijing, 100142, China.
Hou W; Departments of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fu Cheng Road, Hai Dian District, Beijing, 100142, China.
Sun YS; Departments of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fu Cheng Road, Hai Dian District, Beijing, 100142, China. .
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2024 Jan; Vol. 34 (1), pp. 444-454. Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:
Journal Article
MeSH Terms:
Colonic Neoplasms*/diagnostic imaging
Colonic Neoplasms*/pathology
Humans ; Arterioles ; Retrospective Studies ; Neoplasm Staging ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study.
Autorzy:
Wang Y; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun X; Department of Hepatobiliary and Pancreatic Surgery, Huzhou Central Hospital, Huzhou, China.
Chen C; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ge H; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun J; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of General Surgery, Ningbo Fourth Hospital, Ningbo, China.
Li E; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Cai Z; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
Fu Q; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun X; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wu J; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ye M; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Cao W; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chen Q; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wei X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Han X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun K; Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yan Q; Department of Hepatobiliary and Pancreatic Surgery, Huzhou Central Hospital, Huzhou, China.
Huang W; Department of Pathology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Wu L; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zeng Y; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
Zhang Q; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang University Cancer Center, Hangzhou, China; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, China. Electronic address: .
Liang T; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang University Cancer Center, Hangzhou, China; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, China. Electronic address: .
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2024 Mar 31; Vol. 585, pp. 216654. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Humans ; Retrospective Studies ; Prospective Studies ; Neoplasm Staging ; Prognosis
Czasopismo naukowe
Tytuł:
Cervical cancer in Mozambique: Clinical characteristics, treatment and survival of incident cases admitted to the Oncology Service of Maputo Central Hospital in 2016-2018.
Autorzy:
Tulsidás S; Medical Oncology Service, Maputo Central Hospital, Maputo, Mozambique.; EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Universidade do Porto, Porto, Portugal.
Fontes F; EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Universidade do Porto, Porto, Portugal.; Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.; Oncology Nursing Research Unit IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre (Porto.CCC) & (Health Research Network), Porto, Portugal.
Monteiro K; Medical Oncology Service, Maputo Central Hospital, Maputo, Mozambique.
Mussa M; Department of Pathology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Lovane L; Department of Pathology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.; Pathology Service, Maputo Central Hospital, Maputo, Mozambique.
Morais AG; Radiotherapy Service, Maputo Central Hospital, Maputo, Mozambique.
Brandão M; EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.; Department of Medical Oncology, Institut Jules Bordet-Hôpital Universitaire de Bruxelles, Brussels, Belgium.
Lunet N; EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Universidade do Porto, Porto, Portugal.; Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
Carrilho C; Department of Pathology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.; Pathology Service, Maputo Central Hospital, Maputo, Mozambique.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1019-1028. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/epidemiology
Uterine Cervical Neoplasms*/therapy
Humans ; Female ; Mozambique/epidemiology ; Prognosis ; Survival Analysis ; Hospitals ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Analysis of Characteristics and Risk Factors of Patients with Single Gastric Cancer and Synchronous Multiple Gastric Cancer among 14,603 Patients.
Autorzy:
Song DH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Kim N; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Jo HH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.
Kim S; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Choi Y; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Oh HJ; Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea.
Lee HS; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Yoon H; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Shin CM; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Park YS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Lee DH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kang SH; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Park YS; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Ahn SH; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Suh YS; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Park DJ; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Kim HH; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Kim JW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Kim JW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Chang W; Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Korea.
Park JH; Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Korea.
Lee YJ; Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Korea.
Lee KH; Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Radiology, Seoul National University College of Medicine, Seoul, Korea.
Kim YH; Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Korea.; Department of Radiology, Seoul National University College of Medicine, Seoul, Korea.
Ahn S; Division of Statistics, Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, Korea.
Surh YJ; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Pokaż więcej
Źródło:
Gut and liver [Gut Liver] 2024 Mar 15; Vol. 18 (2), pp. 231-244. Date of Electronic Publication: 2023 Mar 29.
Typ publikacji:
Journal Article
MeSH Terms:
Stomach Neoplasms*/pathology
Humans ; Male ; Aged ; Female ; Lymphatic Metastasis ; Gastrectomy ; Risk Factors ; Smoking/adverse effects ; Smoking/epidemiology ; Retrospective Studies ; Neoplasm Invasiveness ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5.
Autorzy:
Benedetti DJ; Division of Hematology/Oncology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Varela CR; Division of Hematology and Oncology, Pediatric Specialists of Virginia, Inova Fairfax Hospital, Fairfax, Virginia, USA.; Janssen Research and Development, Spring House, Pennsylvania, USA.; Division of Oncology, Children's National Hospital and the George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
Renfro LA; Division of Biostatistics, University of Southern California, Los Angeles, California, USA.; Children's Oncology Group, Los Angeles, California, USA.
Tornwall B; Glaukos Corp., San Clemente, California, USA.
Dix DB; Division of Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
Ehrlich PF; Section of Pediatric Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Glick RD; Division of Pediatric Surgery, Zucker School of Medicine at Hofstra/Northwell, Cohen Children's Medical Center, New Hyde Park, New York, USA.
Kalapurakal J; Department of Radiation Oncology, Northwestern University, Chicago, Illinois, USA.
Perlman E; Department of Pathology and Laboratory Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Gratias E; eviCore Healthcare, Bluffton, South Carolina, USA.
Seibel NL; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Geller JI; Division of Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.
Khanna G; Department of Radiology & Imaging Sciences, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Malogolowkin M; Division of Pediatric Hematology-Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California, USA.
Grundy P; Division of Immunology, Hematology, Oncology, Palliative Care and Environmental Interactions, University of Alberta, Edmonton, Alberta, Canada.
Fernandez CV; Division of Pediatric Hematology/Oncology, IWK Health Centre, Dalhousie University, Halifax, Nova Scotia, Canada.
Dome JS; Division of Oncology, Children's National Hospital and the George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
Mullen EA; Department of Pediatric Hematology/Oncology, Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Cancer [Cancer] 2024 Mar 15; Vol. 130 (6), pp. 947-961. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/pathology
Wilms Tumor*/drug therapy
Wilms Tumor*/pathology
Child ; Humans ; Neoplasm Staging ; Progression-Free Survival ; Thorax/pathology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Tytuł:
Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer.
Autorzy:
Sitthideatphaiboon P; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, 1873 Henry Dunant Rd, Pathumwan, Bangkok, 10330, Thailand.
Nantavithya C; Division of Therapeutic Radiation and Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand.
Chantranuwat P; Department of Pathology, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand.
Vinayanuwattikun C; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, 1873 Henry Dunant Rd, Pathumwan, Bangkok, 10330, Thailand.
Sriuranpong V; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, 1873 Henry Dunant Rd, Pathumwan, Bangkok, 10330, Thailand. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 14; Vol. 14 (1), pp. 6146. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/metabolism
Humans ; Biomarkers ; Chemoradiotherapy ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Tytuł:
The long-term outcomes of local tumor destruction versus partial nephrectomy for cT1a non-clear cell renal cell carcinoma and development of prognostic nomograms.
Autorzy:
Qiu J; Department of Urology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.; Institute of Urology, Peking University, Beijing, China.; National Urological Cancer Center, Beijing, China.
Deng R; Department of Urology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.; Institute of Urology, Peking University, Beijing, China.; National Urological Cancer Center, Beijing, China.
Zhao Z; Department of Urology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.; Institute of Urology, Peking University, Beijing, China.; National Urological Cancer Center, Beijing, China.
Tian P; Department of Urology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China.; Institute of Urology, Peking University, Beijing, China.; National Urological Cancer Center, Beijing, China.
Zhou J; Department of Urology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing, 100034, People's Republic of China. .; Institute of Urology, Peking University, Beijing, China. .; National Urological Cancer Center, Beijing, China. .
Pokaż więcej
Źródło:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Mar 12; Vol. 150 (3), pp. 122. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Renal Cell*/pathology
Kidney Neoplasms*/pathology
Humans ; Prognosis ; Nomograms ; Nephrectomy/methods ; SEER Program ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
An analysis of adjuvant chemoradiotherapy versus chemotherapy on the survival rates for patients with stage IB-III uterine serous carcinoma.
Autorzy:
Li S; Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Shanghai, 200090, China. .
Yi Z; Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Shanghai, 200090, China.
Li M; Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Shanghai, 200090, China.
Zhu Z; Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Shanghai, 200090, China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 11; Vol. 14 (1), pp. 5884. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Neoplasms*/pathology
Endometrial Neoplasms*/pathology
Carcinoma*/pathology
Female ; Humans ; Chemoradiotherapy, Adjuvant ; Survival Rate ; Neoplasm Staging ; Chemotherapy, Adjuvant/methods ; Retrospective Studies ; Chemoradiotherapy
Czasopismo naukowe
Tytuł:
Revisiting TNM staging for EBV-related nasopharyngeal carcinoma.
Autorzy:
Dennis M; Department of Medical Oncology, Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Haddad R; Department of Medical Oncology, Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: robert_.
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2024 Mar 11; Vol. 42 (3), pp. 333-334. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma*/pathology
Nasopharyngeal Neoplasms*/pathology
Humans ; Neoplasm Staging ; Nasopharyngeal Carcinoma/pathology ; Herpesvirus 4, Human ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma.
Autorzy:
Du XJ; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Wang GY; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Zhu XD; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
Han YQ; Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Lei F; Department of Nasopharyngeal Head and Neck Tumor Radiotherapy, Zhongshan City People's Hospital, Zhongshan, China.
Shen LF; Department of Oncology, Xiangya Hospital, Central South University, No. 87, Xiangya Road, Changsha, Hunan Province 410008, China.
Yang KY; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Chen L; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Mao YP; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Tang LL; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Li L; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
Wu Z; Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Xu GQ; Department of Nasopharyngeal Head and Neck Tumor Radiotherapy, Zhongshan City People's Hospital, Zhongshan, China.
Zhou Q; Department of Oncology, Xiangya Hospital, Central South University, No. 87, Xiangya Road, Changsha, Hunan Province 410008, China.
Huang J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Guo R; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Zhang Y; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Liu X; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Zhou GQ; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Li WF; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Xu C; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Lin L; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Chen YP; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Chen FP; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Liang XY; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Chen SY; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Li SQ; Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Cui CY; Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Li JB; Department of Clinical Trials Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Ren J; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Chen MY; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China. Electronic address: .
Liu LZ; Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China. Electronic address: .
Sun Y; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China. Electronic address: .
Ma J; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China. Electronic address: .
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2024 Mar 11; Vol. 42 (3), pp. 464-473.e3. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Nasopharyngeal Neoplasms*/diagnosis
Nasopharyngeal Neoplasms*/pathology
Epstein-Barr Virus Infections*/pathology
Carcinoma*/pathology
Humans ; Nasopharyngeal Carcinoma/pathology ; Neoplasm Staging ; Herpesvirus 4, Human ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Comparison of survival outcome of open, total laparoscopic, and laparoscopy-assisted radical vaginal hysterectomy for stage IB2 cervical cancer patients: A multicenter retrospective study.
Autorzy:
Yoon HJ; Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Busan, Republic of Korea.; Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Kwon BS; Department of Obstetrics and Gynecology, Kyung Hee University Medical Center, Seoul, Republic of Korea.
Rho HJ; College of Medicine, University of Ulsan, Ulsan University Hospital, Ulsan, Republic of Korea.
Lee TH; Department of Obstetrics and Gynecology, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Republic of Korea.
Jeong DH; Department of Obstetrics and Gynecology, Busan Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.
Kim KH; Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Busan, Republic of Korea.
Suh DS; Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Busan, Republic of Korea.
Song YJ; Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Busan, Republic of Korea.; Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Gyeongsangnam-do, Republic of Korea.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2024 Mar 08; Vol. 103 (10), pp. e37426.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/pathology
Laparoscopy*/methods
Female ; Humans ; Hysterectomy, Vaginal/methods ; Retrospective Studies ; Neoplasm Staging ; Hysterectomy/methods ; Disease-Free Survival
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies